Otomagnetics

company

About

Otomagnetics produces a magnetic injection delivery system that can deliver therapy to few parts of the body.

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
$100K
Industries
Biotechnology,Delivery,Health Care,Medical,Medical Device,Pharmaceutical,Staffing Agency
Founded date
Mar 1, 2012
Number Of Employee
1 - 10
Operating Status
Active

Otomagnetics LLC, a University of Maryland College Park spin-out, is developing a non-invasive method to effectively deliver drugs and other therapeutic payloads to the inner and middle ear.,The inner ear is behind the blood-labyrinth barrier – vessels that supply blood to the inner ear have walls that are impermeable to most drug molecules, and thus it is a challenge to deliver therapy to treat inner ear diseases. In an animal model, Otomagnetics’ proprietary magnetic injection system has demonstrated drug delivery to the inner ear, and has shown improved dosing and therapeutic effect in preclinical models of tinnitus and noise-induced hearing loss. In an animal model, Otomagnetics’ technology has further shown drug delivery to the middle ear, without the need to puncture the ear drum. Magnetic delivery to the middle ear is being considered as a potential non-invasive treatment option for otitis media (middle ear infections). Note: Otomagnetics products are experimental, and not approved by the FDA for human use.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$100K
Otomagnetics has raised a total of $100K in funding over 2 rounds. Their latest funding was raised on Aug 23, 2016 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 23, 2016 Seed $100K 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Otomagnetics is funded by 1 investors. TEDCO are the most recent investors.
Investor Name Lead Investor Funding Round
TEDCO Seed